GSK plc- New ViiV LA Formulation Potential 4-Month Dosing
Dot Digital Group plc- Interim Results for the Six Months Ended 31st December 2023
Hargreaves Services plc Retirement Benefit Obligation Buy-In Update
Treatt plc Appointment of Chief Executive Officer
HICL Infrastructure plc Interim Update Statement
GlobalData plc Full Year Results for 2023
AstraZeneca- Two datopotamab deruxtecan applications validated in the EU
